← All Sponsors
SPONSOR

Nanjing IASO Biotechnology Co., Ltd.

Total Trials
1
Recruiting
1
Phases
Phase 3
Conditions studied: Multiple Myeloma
NCT06464991 Phase 3
Recruiting

A Phase III Study of Eque-cel in Subjects With Len-refractory RRMM (FUMANBA-03)

Multiple Myeloma
China View Trial →